Glycated Albumin Assay Market

Future Market Insights

Key Insight

The glycated albumin assay market is projected to grow from USD 242.7 million in 2025 to USD 543.7 million by 2035, at a CAGR of 8.4%. Type 2 Diabetes will dominate with a 52.4% market share, while hospitals & diabetic care centers will lead the end user segment with a 61.7% share.

October 25, 2025

Anurag Sharma

281 Pages

Cite this Report

Glycated Albumin Assay Market

https://www.futuremarketinsights.com/reports/glycated-albumin-assay-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbexa Ltd
Abnova Corporation
Beijing Strong Biotechnologies Inc
Biomatik Corporation
Diazyme Laboratories Inc. (General Atomics)
EKF Diagnostics
Geno Technology Inc
Hzymes Biotechnology Co. Ltd
Weldon Biotech India Private Limited

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Glycated Albumin Assay Market

Key Players

Similar Industry Reports